BALYASNY ASSET MANAGEMENT L.P. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$182,000
+82.0%
19,488
+78.7%
0.00%
Q2 2022$100,000
-56.1%
10,906
-36.8%
0.00%
-100.0%
Q1 2020$228,000
-13.0%
17,248
+41.7%
0.00%
+50.0%
Q2 2019$262,000
+33.7%
12,176
-19.3%
0.00%
+100.0%
Q4 2018$196,000
-60.5%
15,085
-27.1%
0.00%
-50.0%
Q3 2018$496,000
-63.8%
20,698
-79.3%
0.00%
-60.0%
Q3 2017$1,369,000
-83.1%
100,000
-81.0%
0.01%
-84.8%
Q2 2017$8,080,000
+131.3%
525,000
+176.3%
0.03%
+106.2%
Q1 2017$3,494,000
+5275.4%
190,000
+1718.2%
0.02%
Q1 2016$65,00010,4500.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Chescapmanager LLC 1,702,110$439,1440.04%
DISCIPLINED GROWTH INVESTORS INC /MN 1,935,718$499,4150.01%
ADAR1 Capital Management, LLC 159,469$41,1430.01%
Y-Intercept (Hong Kong) Ltd 414,731$107,0010.01%
FARALLON CAPITAL MANAGEMENT LLC 1,556,251$401,5130.00%
Virtu Financial LLC 75,987$200.00%
Corsair Capital Management 19,864$5,1250.00%
WEALTH EFFECTS LLC 13,500$3,4830.00%
Cypress Capital Management LLC (WY) 5,000$1,2900.00%
Citadel Advisors 5,000$1,2900.00%
View complete list of CARA THERAPEUTICS INC shareholders